Ellagic Acid from Terminalia arjuna Fruits Protects Against Chromium and Cobalt Toxicity in Primary Human Lymphocytes

Leishmanicidal and immunomodulatory activity of Terminalia catappa in Leishmania amazonensisin vitro infection

Leishmaniases are infectious-parasitic diseases that impact public health around the world. Antileishmanial drugs presented toxicity and increase in parasitic resistance. Studies with natural products show an alternative to this effect, and several metabolites have demonstrated potential in the treatment of various diseases. Terminalia catappa is a plant species with promising pharmaceutical properties. The objective of this work was to evaluate the therapeutic potential of extracts and fractions of T. catappa on Leishmania amazonensis and investigate the immunomodulatory mechanisms associated with its action. In anti-Leishmania assays, the ethyl acetate fraction exhibited activity against promastigotes (IC50 86.07 ± 1.09 μg/mL) and low cytotoxicity (CC50 517.70 ± 1.68 μg/mL). The ethyl acetate fraction also inhibited the intracellular parasite (IC50 25.74 ± 1.08 μg/mL) with a selectivity index of 20.11. Treatment with T. catappa ethyl acetate fraction did not alter nitrite production by peritoneal macrophages stimulated with L. amazonensis, although there was a decrease in unstimulated macrophages treated at 50 μg/mL (p = 0.0048). The T. catappa ethyl acetate fraction at 100 μg/mL increased TNF-α levels (p = 0.0238) and downregulated HO-1 (p = 0.0030) and ferritin (p = 0.0002) gene expression in L. amazonensis-stimulated macrophages. Additionally, the total flavonoid and ellagic acid content for ethyl acetate fraction was 13.41 ± 1.86 mg QE/g and 79.25 mg/g, respectively. In conclusion, the T. catappa ethyl acetate fraction showed leishmanicidal activity against different forms of L. amazonensis and displayed immunomodulatory mechanisms, including TNF-α production and expression of pro and antioxidant genes.

Comparison and Agreement of Toxic and Essential Elements Between Venous and Capillary Whole Blood

For practical and ethical reasons, there is an interest in the use of capillary blood as an alternative to classical human biomonitoring methods that use venipuncture. However, with the exception of Pb, few elements have been studied in detail to understand potential differences in measures between capillary and venous blood. To increase our understanding of the agreement in concentrations of select toxic metal(loid)s and essential minerals in venous and capillary whole blood. Concentrations of As, Pb, Cd, Mn, Cu, Fe, and Se were measured with Inductively Coupled Plasma-Mass Spectrometry in venous and capillary whole blood samples obtained from 49 healthy adult members of the McGill University community in 2016. Measured concentrations of all elements were similar to values reported in background populations. There were strong correlations (i.e., p < 0.001) in measures taken for all these elements between capillary and venous blood. Using Bland-Altman, a deeper investigation of the agreement between the measures found relatively good agreement for blood As, Pb, Cu, and Fe. For blood Cd, Mn, and Se, the agreement between the measures taken in capillary and venous blood was less consistent, though more research is needed to determine if the method can be improved and/or if there are real differences. For the seven elements under investigation, there was relatively good correlation and agreement in measures taken between capillary and venous blood from the same individual. Further research is needed to confirm these findings (particularly from more diverse population groups), expand the number of elements analyzed, and explore the utility of capillary sampling in biomonitoring programs that take samples using traditional venipuncture methods.